Last updated: 4 months ago
Akebia Therapeutics, Inc. 8-K Report: Key Developments on January 13, 2025
Discover the latest SEC filing from Akebia Therapeutics, Inc. detailing significant events affecting operations and stock. Important insights for shareholders and investors.